These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 10623718

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Chemotherapy for retinoblastoma.
    Chan HS, Gallie BL, Munier FL, Beck Popovic M.
    Ophthalmol Clin North Am; 2005 Mar; 18(1):55-63, viii. PubMed ID: 15763191
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Complete regression of retinoblastoma following intra-arterial chemotherapy.
    Ni N, Shields CL, Bianciotto CG, Jabbour PM, Rosenwasser RH, Shields JA.
    J Pediatr Ophthalmol Strabismus; 2011 Jun 07; 48 Online():e23-5. PubMed ID: 21634361
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Treatment of intraocular retinoblastoma with vincristine and carboplatin.
    Rodriguez-Galindo C, Wilson MW, Haik BG, Merchant TE, Billups CA, Shah N, Cain A, Langston J, Lipson M, Kun LE, Pratt CB.
    J Clin Oncol; 2003 May 15; 21(10):2019-25. PubMed ID: 12743157
    [Abstract] [Full Text] [Related]

  • 50. Comparison of retinoblastoma reduction for chemotherapy vs external beam radiotherapy.
    Sussman DA, Escalona-Benz E, Benz MS, Hayden BC, Feuer W, Cicciarelli N, Toledano S, Markoe A, Murray TG.
    Arch Ophthalmol; 2003 Jul 15; 121(7):979-84. PubMed ID: 12860801
    [Abstract] [Full Text] [Related]

  • 51. High Risk Retinoblastoma: Prevalence and Success of Treatment in Developing Countries.
    ElZomor H, Taha H, Aleieldin A, Nour R, Zaghloul MS, Fawzi M, Kamel A, Alfaar AS.
    Ophthalmic Genet; 2015 Jul 15; 36(3):287-9. PubMed ID: 25945688
    [No Abstract] [Full Text] [Related]

  • 52. Vascular perfusion in persistent pupillary membrane of the iris.
    Chang M, Ancona-Lezama D, Shields CL.
    Indian J Ophthalmol; 2019 Oct 15; 67(10):1704-1705. PubMed ID: 31546520
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Using cost-effective intra-arterial chemotherapy to treat retinoblastoma in Chile.
    Ossandón D, Zanolli M, Pérez V, Zúñiga P, Belmar Á, Varas M, Shields CL.
    J AAPOS; 2014 Dec 15; 18(6):617-9. PubMed ID: 25448150
    [Abstract] [Full Text] [Related]

  • 55. Restoration of foveal anatomy and function following chemoreduction for bilateral advanced retinoblastoma with total retinal detachment.
    Shields CL, Materin MA, Shields JA.
    Arch Ophthalmol; 2005 Nov 15; 123(11):1610-2. PubMed ID: 16286630
    [No Abstract] [Full Text] [Related]

  • 56. Resolution of iris neovascularization following chemoreduction of retinoblastoma.
    Patel J, Turaka K, Shields CL.
    J Pediatr Ophthalmol Strabismus; 2010 Oct 21; 47 Online():e1-3. PubMed ID: 21162463
    [Abstract] [Full Text] [Related]

  • 57. Chemoreduction improves eye retention in patients with retinoblastoma: a report from the German Retinoblastoma Reference Centre.
    Künkele A, Jurklies C, Wieland R, Lohmann D, Bornfeld N, Eggert A, Schulte JH.
    Br J Ophthalmol; 2013 Oct 21; 97(10):1277-83. PubMed ID: 23863458
    [Abstract] [Full Text] [Related]

  • 58. Chemoreduction for group E retinoblastoma: comparison of chemoreduction alone versus chemoreduction plus low-dose external radiotherapy in 76 eyes.
    Shields CL, Ramasubramanian A, Thangappan A, Hartzell K, Leahey A, Meadows AT, Shields JA.
    Ophthalmology; 2009 Mar 21; 116(3):544-551.e1. PubMed ID: 19157557
    [Abstract] [Full Text] [Related]

  • 59. Trilateral retinoblastoma with unilateral eye involvement.
    Andrade GC, Pinto NP, Motono M, Chojniak MM, Chojniak R, Bezerra SM.
    Rev Assoc Med Bras (1992); 2015 Aug 21; 61(4):308-10. PubMed ID: 26466209
    [Abstract] [Full Text] [Related]

  • 60. Supraselective injection of intraarterial melphalan as the primary treatment for late presentation unilateral multifocal stage Vb retinoblastoma.
    Aziz HA, Boutrid H, Murray TG, Berrocal A, Wolfe SQ, Pina Y, Dorfman M, Moftakhar R, Fernandes CE, Reichbach J, Aziz-Sultan MA.
    Retina; 2010 Apr 21; 30(4 Suppl):S63-5. PubMed ID: 20224464
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.